These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25546582)

  • 21. Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
    González-Naranjo LA; Betancur OM; Alarcón GS; Ugarte-Gil MF; Jaramillo-Arroyave D; Wojdyla D; Pons-Estel GJ; Rondón-Herrera F; Vásquez-Duque GM; Quintana-López G; Da Silva NA; Tavares Brenol JC; Reyes-Llerena G; Pascual-Ramos V; Amigo MC; Massardo L; Alfaro-Lozano J; Segami MI; Esteva-Spinetti MH; Iglesias-Gamarra A; Pons-Estel BA
    Semin Arthritis Rheum; 2016 Jun; 45(6):675-83. PubMed ID: 26698222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus.
    Mok MY; Chan EY; Fong DY; Leung KF; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):622-8. PubMed ID: 15801016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sectional analysis of adverse outcomes in 1,029 pregnancies of Afro-Caribbean women in Trinidad with and without systemic lupus erythematosus.
    Molokhia M; Maconochie N; Patrick AL; Doyle P
    Arthritis Res Ther; 2007; 9(6):R124. PubMed ID: 18042277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal and Fetal Outcomes in Iranian Patients with Systemic Lupus Erythematosus: A Five-Year Retrospective Study of 60 Pregnancies.
    Karimzadeh P; Shenavandeh S; Asadi N
    Curr Rheumatol Rev; 2019; 15(4):321-328. PubMed ID: 30686262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus.
    Zhang S; Su J; Li X; Zhang X; Liu S; Wu L; Ma L; Bi L; Zuo X; Sun L; Huang C; Zhao J; Li M; Zeng X;
    Lupus; 2015 Oct; 24(12):1267-75. PubMed ID: 25972364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus and pregnancy.
    Reichlin M
    J Reprod Med; 1998 Apr; 43(4):355-60. PubMed ID: 9583068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.
    Sieiro Santos C; Moriano Morales C; Álvarez Castro C; González Fernández I; Díez Álvarez E
    Musculoskeletal Care; 2022 Dec; 20(4):917-925. PubMed ID: 35615936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
    Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII.
    Gui Y; Bai W; Xu J; Duan X; Zhan F; Zhao C; Jiang Z; Li Z; Wu L; Liu S; Yang M; Wei W; Wang Z; Zhao J; Wang Q; Leng X; Tian X; Li M; Zhao Y; Zeng X;
    Chin Med J (Engl); 2022 Sep; 135(18):2191-2199. PubMed ID: 36525605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal wastage in women with anti-Ro(SSA) antibody.
    Watson RM; Braunstein BL; Watson AJ; Hochberg MC; Provost TT
    J Rheumatol; 1986 Feb; 13(1):90-4. PubMed ID: 3486290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with SLE.
    Cheng Y; Li M; Zhao J; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Huang C; Zeng X;
    Int J Rheum Dis; 2018 Mar; 21(3):716-724. PubMed ID: 28296238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pregnancy and systemic lupus erythematosus].
    Moga Sampere I; Formiga Pérez F; Canet González R; Pac Ferraz M; Mitjavila Villero F; Fernández-Nogués F
    Med Clin (Barc); 1993 Oct; 101(14):530-3. PubMed ID: 8231397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
    Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
    Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus.
    Li M; Zhang W; Leng X; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Zhang F; Zhao Y; Zeng X;
    Lupus; 2013 Oct; 22(11):1192-9. PubMed ID: 23963101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus.
    Nahal SK; Selmi C; Gershwin ME
    J Autoimmun; 2018 Sep; 93():16-23. PubMed ID: 30056945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus.
    Li J; Leng X; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Tian XP; Li M; Zhao J; Zhang FC; Zhao Y; Zeng X
    J Immunol Res; 2014; 2014():809389. PubMed ID: 24864270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
    Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
    Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
    Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.